Newstral
Article
wsj.com on 2015-03-02 15:19
Cardinal Health to Buy J&J's Heart Business for $1.94 Billion
Related news
- Cardinal Health to buy J&J unit for about $1.94 billionLA Times
- J&J to buy heart medical tech firm Abiomed for $17.3 billion - Tue, 01 Nov 2022 PSTThe Spokesman-Review
- Cardinal Health offers to buy J&J unit for $2BThe Salt Lake Tribune
- Patent for J&J's Remicade invalidatedThe Salt Lake Tribune
- J&J to buy hair care products maker Vogue for $3.3-billionThe Globe and Mail
- J&J's 2014 revenue rose, profits soaredPhilly.com
- J&J's single-shot vaccine 66% effectivereuters.com
- EU regulator recommends using J&J's one-shot vaccinelasvegassun.com
- J&J's booster shown effective against Covid hospitalizationPOLITICO
- CDC panel recommends Pfizer, Moderna COVID shots over J&J'slasvegassun.com
- U.S. calls for pause on J&J's COVID-19 vaccinereuters.com
- Cardinal Health paying $1.1 billion for distributorThe Salt Lake Tribune
- What To Make Of J&J's First Xarelto Lawsuit LossForbes
- Video: Cyber bug in J&J's insulin pumpThe Globe and Mail
- EU considers booster doses of J&J's COVID-19 vaccinedailyherald.com
- J&J's single-dose Covid vax gets emergency use nodThe Times of India
- J&J's deceptive marketing fuelled US opioid crisis, court hearsSydney Morning Herald
- VJ&J's one-dose vaccine offers hope in virus fightvideo.startribune.com
- J&J accepts offer from Cardinal Health for Cordis unitThe Findlay Courier